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Bourret, Kristin, H., M.S., September 2001 HHP
Method development for the quantitation of glucose and [6,6-^H] glucose in human 
plasma samples using LC/MS.
Director: Dr. Brent Rul
The purpose of this research was to develop a method that accurately detects the 
enrichment of [6,6-^H] glucose in human plasma samples via LC/MS. Traditionally, the 
analysis of [6,6-^H] glucose has been conducted using GC/MS. The benefit to a LC/MS 
method is the avoidance of derivatizing glucose for analysis as is required with GC/MS. 
Method: Plasma samples were acquired from five female subjects participating in an 
exercise study. Each subject performed a 60-minute cycle ergometry exercise bout while 
being infused with [6,6-^H] glucose. Additional plasma was obtained from a previously 
conducted exercise study, which acquired data by GC/MS. Three different ionization 
techniques were explored; negative ion electro spray (ESI) LC/MS, negative ion 
atmospheric pressure chemical ionization (APCI) LC/MS, and positive ion ESI LC/MS. 
Results: The data with the best signal, peak resolution, and signal to noise ratio were 
acquired using positive ion ESI LC/MS. Data did not match previously measured 
enrichments by GC/MS and predicted trends were not exhibited by the freshly acquired 
plasma samples. Accurate results were obtained when analyzing glucose standards 
mixed in DDI water and spiked with 1-5% [6,6-^H] glucose (R  ̂= 0989). On the 
contrary, data resulting from glucose standards again spiked 1-5% with [6,6-^H] glucose 
but that were from plasma showed no discernible trends (R  ̂= 0.187). Discussion: The 
problem with the analysis of [6,6-^H] glucose was unique to samples coming from 
plasma. The isotopic peaks were larger than predicted for background samples and for 
samples drawn after the infusion started. A contaminant molecule with the same 
molecular weight as the isotope was suspected. Sorbitol, a reduced form of glucose has 
the nrolecular weight of 182 amu and was pursued as a candidate. Glucose standards in 
DDI water spiked with sorbitol showed a ten-fold increase in the measurement of 
theoretical enrichments (R  ̂= 0.998). Conclusion: Further research is needed in the 
development of a LC/MS method. Techniques for better separation of glucose from 
contaminant molecules should be employed. The use of carbohydrate LC columns 
specifically made to separate monosacharrides may improve separation, as may the use of 
a quadrupole mass analyzer.
ii
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Chapter One: Introduction
In 1959 Steele established a method for measuring the turnover rate and size o f  
the body’s glucose pool using a stable isotope (Steele, 1959). This method has been 
widely used in the field o f  exercise science to measure the appearance rate o f  metabolic 
substrates found in the blood. Steele’s method has since been modified by Wolfe and is 
utilized today by researchers when measuring glucose kinetics in vivo (Wolfe, 1992). 
Metabolic research using [6,6-^H] glucose has become increasingly important to the field 
o f exercise science and especially carbohydrate feeding studies. Quantitation o f  glucose 
metabolism involves the use o f  stable and/or radioactive isotopes. In order to limit the 
risk incurred by human subjects, stable isotopes are employed to avoid any ill effects o f  
radiation. The use o f  [6,6-^H] glucose enables researchers to assign relative proportions 
o f carbohydrate oxidation rates to either glycogen stores or blood glucose.
An understanding o f glucose metabolism is needed in order to provide accurate
recommendations on nutrition, training, and performance for competitive athletes.
Glucose kinetics is o f  particular importance to the endurance athlete who may deplete
carbohydrate stores over the course o f  an event and must rely heavily on exogenous
sources o f  glucose. Performance and rate o f  recovery may be enhanced with proper
carbohydrate intake before, during, and after competition (Febbraio et al., 2000). A
better understanding o f glucose metabolism will not only benefit athletes but also those
with various medical conditions or job related environmental stresses. People working in
very hot or cold ambient temperatures, patients suffering fi-om thermal injuries, and
1
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pregnant women face conditions that alter energy expenditure and thus energy intake. 
The elucidation o f  nutritional requirements for these populations as well as athletes may 
be aided by metabolism studies that utilize [6,6-^H] glucose.
Analysis o f  [6,6-^H] glucose can lead to the determination o f relative blood 
glucose and stored glycogen oxidation rates. This requires the use o f  a mass 
spectrometer (MS), which evolved from work done in 1912 by J.J. Thonqjson (Siuzdak, 
1996). MS provides information on a molecule’s molecular weight and/or structure. In 
exercise physiology, mass spectroscopy has been used for the analysis o f  isotope data 
gathered from metabolic studies. The MS detects the enrichment o f  an isotopic tracer 
molecule within the tracee pool. It is this enrichment that enables the quantitation o f  a 
particular metabolite’s disposal and uptake rates. Traditionally, metabolic studies using 
[6,6-^H] glucose have used gas-chromatography mass spectrometry (GC/MS) (Febbraio 
et al, 2000, Marmy-Conus et al., 1996, Freidlander et al., 1998, Zderic et al., 2001). The 
GC/MS is a gas chromatographic system that uses a mass spectrometer as a detector. The 
GC separates compounds that are thermally stable, chemically inert, and volatile at 
temperatures generally below 300® C (James et al., 1952). The sample is vaporized and 
carried through a column by an inert gas, usually helium. Most substances within the 
body are not thermally stable, chemically inert or volatile.
The five OH functional groups in hexoses like glucose produce strong
intermolecular forces that decrease the molecules ability to vaporize as required for the
GC. Therefore, glucose must be made into a derivative for GC/MS analysis.
Derivatization masks the OH groups and increases the molecules volatility, which
2
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facilitates GC/MS analysis. The pentaacetyl derivative o f  glucose is used for GC/MS 
analysis. Assumptions must be made that all five o f  the OH functional groups acquire an 
acetyl group with 100% conversion (Wolfe, 1992). I f  one o f  the five functional groups is 
not converted, the MS will not detect the molecule as glucose, possibly lowering 
sensitivity. This presents an appealing challenge to find a way to analyze glucose in its 
native, underivatized form.
James McLafferty developed liquid-chromatography mass spectrometry in 1973 
(Siuzdak, 1996), seventeen years after the advent o f  GC/MS. This kind o f  interfacmg 
with the mass spectrometer does not require the derivatization o f glucose and is, 
therefore, more suitable for analyzing biological substrates. Currently, there are several 
common LC interfacing techniques available. These techniques differ in their optimal 
analyte, ionization type, and maximum solvent flow rates (Chapman, 1998). The 
evolution o f  electrospray ionization (ESI) has facilitated the use o f LC/MS methods for 
polar molecule analysis, negating the need for derivatization (Chapman, 1998 and Gelpi 
1995). ESI is accomplished by charging the sample liquid in a narrow-bore metal 
capillary. Small charged droplets are formed. Eventually desorption o f the sample 
occurs firom the droplets and it is sent into the mass spectrometer. ESI is the best 
interfacmg candidate for establishing a method to analyze glucose fi’om plasma samples 
because o f  its mild ionization and low thermal input.
Reid et al., 1990 proposed a methodology in 1990 using thermospray LC/MS to
analyze enrichments o f  [1-^Hi] glucose in human plasma samples. To date, this is the
only LC/MS method used for the analysis o f  plasma glucose enrichments. The method
3
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uses negative ion thermospray LC/MS to measure the enrichment o f  [1-^Hi] glucose in 
plasma samples. Since this work, electrospray (ESI) LC/MS has replaced thermospray 
and revolutionized biomolecular analysis. The purpose o f  our research is to develop a 
LC/MS method for the determination o f carbohydrate utili2ation  patterns.
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Problem
To develop a method for the evaluation o f [6,6-^H] glucose enrichments using LC/MS. 
This study seeks to determine optimal sample prep, LC, and mass spectrometer 
conditions for proper analysis. The data provided will help determine if LC/MS is an 
appropriate method for this type o f  analysis.
Research Hypothesis
Hypothesis One
Plasma glucose enrichments usir^ [6,6-^H] glucose can be deterrnined using LC/MS. 
Justification
LC/MS is an appealing technique for glucose enrichment analysis since glucose 
derivatization is not necessary.
Hypothesis Two
The results obtained by LC/MS should mirror results obtained via GC/MS.
Justification
Both GC/MS and LC/MS require the same purification steps with the exception o f 
derivatization. Assuming this step does not profoundly change the amount o f  glucose in 
each sample, LC/MS should detect similar enrichments.
Significance o f the Study
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
There is widespread use o f the [6,6-^H] glucose isotope in metabolic research. To our 
knowledge GC/MS is the only method utilized in these studies. This method requires the 
addition o f an acetyl functional group to all five o f  the OH functional groups o f glucose. 
Only one published study has used LC/MS to find enrichments for plasma glucose and no 
studies have been published using ESI LC/MS for the [6,6-^H] glucose isotope.
Rationale for the Study
The development o f  an LC/MS protocol for the analysis o f  plasma glucose will 
complement existing methods o f analysis, offering the possibility o f  examining multiple 
analytes, and permit high-throughput to researchers with the option o f  using LC/MS. 
Analyzing glucose in its native form eliminates concern over derivatization and artifact 
production.
Limitations
1/ Sensitivity. TOP MS is not as sensitive as a quadrupole MS for single ion 
monitoring (SIM) conditions.
2/ Sample prep. Plasma samples were thawed and refrozen several times 
throughout the course o f analysis. To avoid degradation o f samples, they were only 
thawed for the time needed to collect sample and immediately refrozen. Additionally, 
once purified samples were transferred into auto sampler vials they were kept frozen in -  
80®C freezer.
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3/ Plasma samples. A limited volume o f  plasma was available to perform 
experiments. Old samples from a previous study collected four years prior to this 
research were used during method development.
Definition o f Terms
LC/MS. Liquid-chromatography mass spectrometry refers to a liquid chromatography 
system with a mass spectrometer as a detector.
GC/MS. Gas-chromatography mass spectrometry refers to a gas chromatography system 
with a mass spectrometer as a detector.
Tracer. Labeled metabolite infused to study a metaboHte o f  interest.
Tracee. The metabolite whose kinetics are being examined.
Ra. The rate o f appearance o f a given metabolite into the circulation.
Rd. The rate o f disposal o f  a given metabolite out o f  the circulation.
Isotopic enrichment. The ratio o f  tracer to tracee determined with liquid 
chromatography-mass spectrometry. Used to calculate Ra and Rd.
[6»6-^H] Glucose. A glucose molecule in which the two hydrogens on carbon six have 
been replaced with deuterium. This molecule is stable and used to measure glucose 
kinetics in vivo.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chapter Two: Methodology 
Materials and Methods
Human Subjects
Plasma samples were obtained from five recreationally active female students from The 
University o f  Montana campus. Subjects were 18-23 years old and volunteered for this 
study. Subjects completed consent forms (Appendix) and were made aware o f  the rigor 
o f the study as well as risks involved with the procedures. Subjects reported to the lab for 
two tracer trials once during the mid follicular and once during the mid luteal phase o f  
their menstrual cycle. The University o f  Montana Institutional Review Board (IRB) and 
Human Subjects Committee approved the study (Appendix).
Body composition
Hydrostatic weighing with a digital scale (Exertech, Dresbacfr MN) at residual lung 
volume was used to calculate percent body fat and fat free mass. The residual lung 
volume was calculated using a Helium dilution technique using calculations developed 
by Goldman and Becklace. Calculations for percent body fat utilized body density and 
age/gender specific equations (Lohman, 1992).
Exercise tests
Subjects were instructed to refrain from the ingestion o f  nicotine, caffeine, alcohol, and
food 10 hours prior to exercise trials and to refrain from exercise 15 hours before exercise
8
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testing. Subjects reported to the lab for peak VO2 (volume o f  oxygen consumed)/ lactate 
threshold determination one week to one month before experimental trials began. All 
exercise tests were conducted on a Monark cycle ergometer (Model 824E). A modified 
TrueMax 2400 Parvo-medics (Salt Lake City, UT) metabolic system was used to analyze 
expired oxygen and carbon dioxide concentrations. The system was equipped with a 
Hans Rudolph (Hans Rudolph, Inc., Kansas City, MO) medium-flow (10-120 Lm in’ )̂ 
pneumotach along with Beckman oxygen and carbon dioxide analyzers. Prior to each 
test the metabolic system was calibrated with known concentrations o f  O2 and CO2 
(15.2% and 5.17%). The system was recalibrated if  gases were not within 5.0% o f  known 
values. Flow rate was calibrated using a 3L syringe per manufacturer’s instructions 
(Parvo-medics Operators Manual, 1999). During testing, heart rate was continuously 
monitored using a telemetry chest strap and monitor (Polar, Port Washington, NY).
Peak VO2 /  Lactate Threshold cycle test
The first lab visit was a peak VO2/  lactate threshold test. Prior to the test a venous
catheter was placed in an antecubital vein for blood sampling throughout exercise. In
order to prescribe exercise intensities, blood samples were collected for lactate threshold
determination. VCO2 , VO2 and respiratory exchange ratio (RER) were collected every 20
seconds. The protocol consisted o f  a 5-minute warm-up followed by 2-minute stages
starting at 58.8 W and increased approximately 10 W each stage until volitional
exhaustion. Peak VO2  was defined as reaching two o f the following three criteria: an
RER value above 1.0, a plateau in VO2 and a  HR greater that 95% o f  predicted maximal
9
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HR. Blood samples o f  1 -2 ml were drawn the last 20 seconds o f  each 2 minute stage. 
The test was stopped when the subject met two o f the three peak VO 2 criteria. 
Immediately after each sample was collected, 0.5 ml o f  whole blood was added to a test 
tube containing 1 ml o f  chilled 7% perchloric acid and frozen at -20 ® C until samples 
were thawed and centrifuged. The supernatant was removed and lactate concentrations 
were later determined using a spectrophotometric method. The estimated lactate 
threshold power output was determined as the last workload before a nonlinear increase 
in blood lactate concentration. The highest recorded heart rate was reported as the 
subject’s maximal heart rate.
Experimental Trial
Subjects reported to the lab at 6:00 a.m., approximately 10 hours fasted. Indwelling
catheters (18-20 gauge Teflon) were placed in an antecubital vein o f  each arm and kept
patent with a continuous saline drip (0.45% sodium chloride). A background sample o f  4
ml was drawn before a primed constant infusion o f  the isotope [6,6-^H] glucose
(Cambridge Isotope Laboratories, Andover, MA) was started. The 10-minute priming
dose was 4.0 pmol/kg min"', which was followed by a 50-minute constant infusion at a
rate o f  0.40 pmol/kg min'* in order to reach isotopic equilibrium. A Harvard infusion
pump (Cambridge Isotopes Laboratories, Woburn, MA) depressed a 60-ml syringe
containing the isotope. Next, an oral glucose bolus o f 2.0 g o f  glucose / kg fat free mass
(FFM) (Fisher) was given in a 22% solution. The subject remained sedentary for 20
minutes before beginning the exercise session at 90% o f  lactate threshold on a  cycle
10
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ergometer. Blood samples were taken every 5-10 minutes throughout exercise (see 
timeline).
Analysis
Blood sampling timeline:
Priming dw e Constant infusion 0.40 (xmoi/kg min'^
4.0 pimol/kg min '
CHO Drink
-60 -2 0 10 20 25 30 40 50 60
Figure 2.1. Total blood volume drawn = 65 ml, each sample will contain from 4-10 ml + 
1.5 ml discard.
Blood samples were collected in EDTA treated tubes for the analysis o f  glucose and in 
plain glass tubes containing chilled 7% perchloric acid for plasma lactate. Glucose and 
lactate concentrations were analyzed using an enzymatic (Sigma) spectrophotometric 
technique (Milton Roy Spectronic 401). Samples drawn for each timepoint were 
analyzed for plasma glucose and samples drawn at time 0, 30, and 60 o f exercise were 
analyzed for plasma lactate. Samples from each subject were analyzed together in 
duplicate.
11
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Hardware and Reagents
Polypropylene test tubes with cap, 12 x 75 mm were obtained jfrom Fisher Scientific 
(Pittsburgh, Pennsylvania, USA). Zinc sulphate (0.3 N, 14-4) barium hydroxide (0.3 N, 
14-3) and mixed-bed ion exchange resin (TMD-8) were obtained from Sigma Chemical 
Co. (St. Louis, Missouri, USA). [6,6-^H] Glucose was obtained from Cambridge Isotope 
Laboratories (Andover, Massachusetts, USA). D-Glucose (anhydrous) was obtained 
from Mallinckrodt Baker, Inc. (Paris, KT, USA).
Apparatus
High performance liquid chromatography/mass spectroscopy (HPLC/MS) was 
carried out using a MicroMass LCT mass spectrometer running in the positive ion mode. 
The HPLC was performed with a Waters 2790 pump on a Symmetry C,g (3.5 pm, 2.1 x 
50 mm i.d.) (Waters Corporation, Milford, Massachusetts, USA), 20 pi injection with a 
flow rate o f  iml/min (2/98 acetonitrile: water). Glucose and [6,6-^H] glucose were 
observed as their sodiated species yielding mass spectral peaks corresponding to 
[M+Na]^ o f 203 (180 + 23) and 205 (182 + 23), respectively.
The mass spectrometer was equipped with the electrospray source with the 
settings: capillary voltage = 3200 V; sample cone = 10 V; extraction cone = 5 V; ESI 
desolvation temperature = 400 ®C; source temperature = 1 5 0  ®C; desolvation gas flow ~ 
650 1/hr.
12
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4 mt into 
EDTA tube 
for olucose
Remaining
plasma
archived
Samples 
reconstituted in 
500 )xl DDI 
water
1/2 of supernatant 
into plastic tube for 
[glucose] frozen - 
20
500 nl plasma + 
750 ul Ba(0H)2
750 pi ZnS04 
Vortex
Subject's Blood 
collected in 
non-
heparinized
syringe
On ice for 20 
minutes then 
centrifuge for 
20 minutes
4 ml into plain 
glass tubes for 
Estrogen and 
Progestertme 
at Time point -
Tubes into -80 
degree C freezer for 
10-15 minutes and 
then into lyophilizer
Add supernatant 
to mixed-bed ion 
exchange column 
Rinse with 400 pi 
DDI water x 5
3/4 of supernatant 
into plastic tubes 
for isotopic 
enrichment of 
glucose frozen at 
-20
Transfer into HPLC 
auto sampler vials 
for mass 
spectrometric 
analysis
1 ml into PGA tubes 
for lactate and 
glycerol at Time 
points 0,30,60
3 ml into plain glass 
tubes for Insulin at 
Time points -2, 0, 30 
.60
Figure 2.2. Glucose isolation and purification from obtaining subjects blood to LC/MS 
analysis.
13
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Sample preparation
Plasma serum samples (500 pL) were added to 12 x 75 mm test tubes and 
deproteinized by the addition o f  barium hydroxide (0.3 N, 750 pL) and zinc sulphate 
(0.3M, 750 pL), vortexed and stored on ice for 20 minutes. The tubes were then 
transferred to the speed vac centrifuge and spun at maximum speed for 20 minutes in a 
cold room at 4 ®C. The tubes were removed and the supernatant was added to a mixed- 
bed ion exchange column (3 mL disposable syringe, filled to 1.5 mL, Becton Dickinson 
and Company, Franklin Lakes, NJ) and the column was washed five times (400 pL) with 
double de-ionized (DDI) water (2500 pL, total volume). The resultant solution was 
lyophilized and the residue was reconstituted in DDI water (500 pL), transferred to an 
HPLC auto sampler vial and kept frozen at —80 ®C until HPLC/MS analysis. The thawed, 
vortexed samples were injected into the HPLC/MS (20 pL) and the mass spectral peaks 
corresponding to 203 and 205 were monitored. The ratio o f 205 to 203 was calculated 
for each time point.
Standards
Two sets o f  standard solutions were prepared, one in water and the other in 
plasma. Stock solutions o f  [6,6-^H] glucose (Cambridge Isotope Laboratories, Andover 
MA) and D-glucose (Mallinckrodt Baker, Inc., Paris, KT) at 5 mM concentrations were 
prepared in DDI water. Serial dilutions were made at 1%, 2%, 3%, 4%, and 5% [6,6-^H]
14
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glucose enrichments. A second set o f  standard stock solutions were mixed. A 10 mM 
[6,6-^H] glucose solution was added to aliquots o f  a 6.97 mM plasma sample. Again 
dilutions were made and plasma samples were spiked from 1 -5% with [6,6-^H] glucose.
Analysis o f  Standards
The above standard solutions were prepared to determine the accuracy o f  the 
LC/MS values. Analysis o f  standards was conducted in a manner that would also assess 
the effect o f  the sample prep protocol as expressed in the procedure below.
Procedure:
The blank (100) pi, 1%, 2%, 3%, 4%, and 5% standards in water were transferred to 
HPLC auto sampler vial and analyzed before any sample prep occurred. Deproteinizing 
agents were added to the remaining solution as stated in sample prep section but with 
volumes adjusted, put one ice for 20 minutes, centrifuge in the cold room for 15 minutes, 
and the supernatant was transferred into HPLC auto sampler vials for analysis. With 250 
pi o f  the above standards the full sample prep (deproteinization, chromatography and 
lyophilization) was conducted before analysis. Because proteins in the plasma may clog 
the HPLC sampler, spiked plasma standards were only analyzed after the deproteinizing 
step and after conplete prep.
Statistical Procedures
1) Glucose (pre exercise 0, 10, 20, 30, 40, 50, and 60 minutes o f  exercise) and lactate
(time 0, 30, and 60 o f  exercise) concentrations were determined using a SuperAnova
15
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statistical package (Abacus, Inc, Berkeley, CA). The level o f  significance was set at an 
overall experimental alpha o f 0.05.
2) Descriptive variables VO2 peak (ml kg'* min'*) and % VO 2  peak at lactate threshold 
were reported expressed as mean plus or minus standard error.
16
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C h ap te r Three: Results an d  Discussion
Subject characteristics
Plasma samples were taken from five recreationally active females tested during the 
follicular and luteal phases. The physical characteristics are reported in Table 1. None 
o f  the subjects were using oral contraceptives and all were menstruating normally for the 
six months prior to the study.
Table 3.1. Physical characteristics o f  female subjects. Expressed as mean ± standard 
deviation (n = 5).
Age (years) 20 + 1.7
Height (cm) 166.8 ± 6.9
Body Mass (kg) 64.69 + 12.7
Body Fat (%) 19.94 ± 4.3
Maximum Heart Rate (bpm) 193 ± 7
VO 2 peak (1/min) 3.07 ± 0.5
VO2 peak (ml kg Vmin) 47.84 + 4.4
% V 0 2  peak @ lactate threshold 63.10 + 5.0
17
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Workload Intensities during exercise trials
The intended exercise intensity was 90% VO2 at the lactate threshold (% VO2 @ LT). 
No differences were found w ith respect to workload intensity during the 60-minute 
exercise trials.
Table 3.2. Workload intensities for the exercise trial reported expressed as mean + 
standard deviation (n = 5). Early refers to 1-30 minutes o f  exercise and late represents 
31-60 minutes o f  exercise during each trial.
Follicular %V02 Luteal %V02 peak 
peak (ml/kg /min) (ml/kg/min)
Early Late Early Late
59.11+ 4.45 58.86 + 4.84 57.72 + 4.84 59.76 + 5.66
Plasma glucose and lactate concentrations
There were significant dififerences in plasma glucose concentrations at time 0 and 10 o f  
exercise after the oral bolus (2.0 g / kg FFM) was given. By minute 20 o f exercise, 
plasma glucose concentrations were normalized. Subjects demonstrated an excellent 
ability o f  normalizing blood glucose concentrations after such a large load. Plasma 
lactate was determined for time 0, 30, and 60 minutes o f  exercise. There were no 
significant differences between the menstrual phases but a main effect for time is
18
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indicated in Figure 3.2. Significant differences exist between time 0 and both exercising 
time points (30 and 60).
7.5
f  6.5 -
-I 6 :
15.5 :
O follicular 
■  luteal
4.5
pre drink 0 10 20 30 40 50 60
Pre exercise and exercise time (min)
Figure 3.1. Plasma glucose response due to oral glucose load given 20 minutes before 
exercise (n = 5).
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3.5
2.5 O follicular 
■  luteal
1.5
T
0 30 60
Pre exercise exercise time (min)
Figure 3.2. Plasma lactate concentrations illustrating a main effect for time at time 30 
and 60 o f exercise (n = 5).
Substrate Oxidation
As indicated by Figure 3.3, subjects oxidized more carbohydrate during the luteal phase 
than follicular phase. Previous research in our lab (Zderic et al., 2001) found the opposite 
trend, reporting increased fat oxidation in the luteal phase, associated with elevated levels 
o f  estradiol and progesterone. The only differences between the previous study and the 
present were the carbohydrate drink before exercise and a  longer duration o f  exercise at 
the chosen intensity.
20
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Substrate Oxidation 1-60 minutes
120
i
Î
f
£
100
■  FAT 
OCHO
F igure 3.3. Contribution o f fat and carbohydrate to substrate oxidation (1 = follicular, 2 
= luteal).
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Plasma prep  fo r  LC/M S analysis
Ba(OH ) 2  and ZnS0 4  were added to plasma samples to precipitate out proteins. The 
samples were centrifuged and the supernatant was added to mixed-bed ion exchange 
columns so that molecules other than glucose would be removed increasing the purity o f 
each sample. Each column was washed with DDI water and then lyophilized. Samples 
were reconstituted in DDI water with the same volume o f the original plasma sample.
Ionization techniques explored 
Negative ion electrospray LC/M S
The first technique utilized to detect glucose and [6,6-^H] glucose was negative ion ESI- 
LC/MS. Glucose, with a mass to charge ratio (m/z) o f 179 was observed with decent 
signal intensity (Fig 3.4). However, the isotopic peak at m/z 181 sits in the background 
noise (Fig 3.5). Areas under this peak were not quantitated because o f  the large signal to 
noise ratio. When comparing spectra from the front and back end o f the total ion 
chromatogram, the 181 peak was shifted slightly as indicated in Figure 3.6. The tracer 
tracee ratio from the front end o f  the peak was generally smaller than that calculated from 
the back end. This was consistently observed with plasma samples analyzed in the 
negative ion ESI mode. These observations led to the exploration o f other ionization 
techniques and the question o f  whether or not other molecules were co-eluting at the 
isotopic peak.
22
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T ed 's S am ples am  A7&  NH40Ac KB170
Glucose Study 2 9
31-MAY-2CW110:16:26
TOP MS ES-
TIC
6.22e3
0.54lO O n
Time
0 50 2.50 3.001.00 1.50 2.00
Figure 3.4. Total ion chromatogram (TIC) in negative ion ESI.
Ted's Samples am 47j5 NH40Ac KBI 70
Glucose Study 2 9 21 (0.356) Cm (14:22)
^QO 119 0211 ^ 179,0459
%- 352.9692
239.0437 1.9686
,356.9696 
I I 450 9324 554.9886 
|t|
31<MAY^001
10:16:26
TOP MS ES- 
899
100 200 300 400 500 600 700 800 900 1000
m/z
Figure 3.5. Background noise in negative ion ESI.
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r e d 's  Sam ples am 47 j5 NH40AC KB170 31-MAY-2001
10:16:26
Glucose studv 2 9 27 f0.456^ Cm f27;401 TOP MS ES-
341179.0459lOOn
■  %- 180.9902
177.9652
TOP MS ES- 
877
glucose study 2 9 21 (0.356) Cm (15:22) 
100-, 179 0459
177.9652
180.0393
n\fz
178 179 180 181 182
Figure 3.6. Mass shift illustrated in negative ion ESI. The top (0.439) peak represents a 
scan fi-om the back end o f the TIC and the bottom represents a scan fi-om the fi-ont o f  
peak (0.356).
Negative ion APCI
The next method explored was negative ion atmospheric pressure chemical ionization
(APCI). With this method, initial data showed improved signal intensity, lower
background and improved peak resolution (Fig 3.7 and 3.8). All samples fi*om the
exercise study were analyzed using this method looking at peaks 181/179 and the
chlorine-associated glucose at 217/215. Chlorinate-associated peaks were analyzed
because they consistently appeared in the spectra and both peaks were well above the
background noise. The 217 and 215 peaks were promising prospects to quantitate
enrichments because their signal intensities were not as dramatically different as the 179
24
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
and 181 peaks. Slight differences in the tracer peak intensity did not change the tracer 
tracee ratio (TTR) as drastically. But with either set o f  peaks tracer tracee ratios were 
higher than predicted especially for background samples (Table 3.3). Additionally, when 
enrichments were plotted the data did not illustrate any discernible trends (Fig 3.9). The 
high background values produced negative enrichments for time points occurring after 
the tracer infusion started. When correcting for background values (taking theoretical 
background values) there was still no observable trend. Enrichments are predicted to stay 
constant over the course o f  exercise but with a possible drop towards the end. These 
trends were not observed.
LDL 2 KB170 20^IUN^2001
20:28:46
Glucose Study 328 40 (0.668) Cm (34:43) TOP MS AP-
179.0909100-1
215.0573
180.0845 217.0636196.0962 .222.1075206.1080 212.0776
mtz
175 180 185 190 195 200 205 210 215 220 225
Figure 3.7. Improved background noise in negative ion APCI.
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LDt-2 KBI 70 20^UN-2001
20:28:46
TOP MS AP-
179.0909100-,
160.0645 181.1036
181
m/i
179 180 182
Figure 3.8. Peak resolution in negative ion APCI.
Table 3.3. Representative subject’s tracer tracee ratio (TTR) and enrichment (E) for 
glucose (181/179) and glucose + chlorine (217/215). E = sample TTR - background 
TTR.
Timepoint
-60
-2
0
10
20
25
30
40
50
55
60
E E
181/179 181/179 217/216 217/215
7.412653 0 39 .78595  0
7 .1 4 4 3 0 2 -0 .2 6 8 3 5 4 0 .3 9 1 9 4 0 .6 0 5 9 8 2  
4 .817495  -2 .59516 37 .79623  -1 .98972  
3.826506 -3 .58615 36 .67586  -3.1101  
4 .109398 -3 .30325 34 .53292 -5 .25304  
4.800821 -2 .61183 36 .53297 -3 .25298  
5.115824 -2 .29683 38 .09162  -1 .16303  
3.44659 -3 .96606 35 .86782  -3 .91813  
3.552059 -3 .86059 35 .20992  -4 .57603  
3.800325 -3 .61233 35 .48625  -4 .2997  
4.994991 -2 .41766  3 8 .5 1 6 1 2 -1 .2 6 9 8 3
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a ■
|E  1S1A79 e 1X7 ms
Figure 3.9. Time vs. enrichment for a  representative subject in the exercise study. 
Enrichments for 181/179 and 217/215 peaks are shown.
Chromatography
Chromatography was experimented with while searching for better separation o f  glucose 
from other molecules. The purpose o f  running the samples through a LC column was to 
increase purity and decrease the chance for a co-elutant at the tracer peak. Flow rates, 
size o f  the column, and solvent conditions were varied (water, acetonitrile, and
ammonium acetate). Unfortunately, running the samples through the column did not
27
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improve background, separation, or ionization. Without any improvement in the data 
another ionization method was investigated and loop injections were made.
Positive ion electrospray [M +Na] 205/203
Through communication with another laboratory it was recommended to look for the 
sodiated peak [M + Na] o f  glucose using positive ion ESI. The peaks appeared at m/z 203 
and 205 with good signal intensity. This form o f  ionization (cationization) is well suited 
for carbohydrates because o f  the electronegativity associated with their hydroxyl 
functional groups. Standard solutions made up in double deionized water were prepared 
to test the instrumentation before more plasma was used from the exercise study.
Glucose enriched 1-5% with [6,6 glucose was run through the mass spectrometer 
(Fig 3.10). Actual enrichments were plotted against theoretical values. The mass 
spectrometer accurately measured the enrichments for the standards in water as indicated 
by the standard curve (R^ = 0.9888) (Fig 3.15). The accuracy o f  the instrument led to the 
belief the method would also measure plasma samples correctly. Therefore, two sets o f  
plasma samples from the exercise study subjects were prepared and analyzed for 
enrichment. Again the enrichments did not indicate the predicted trend and the samples 
that were previously analyzed via GC/MS did not match LC/MS results (Table 3.4 and 
Fig 3.16). Until this stage o f  method development, it was thought problems with the data 
were due to the ionization method. In order to elucidate why the plasma samples were 
not accurately detected, a set o f  spiked plasma standards were prepared as described in
28
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the methodology section (Fig 3.11, 3,12 and 3.13). When analyzing the spiked plasma 
standards a poor correlation was observed between theoretical values and experimental 
values (R^ = 0.187) (Fig 3.16). It became clear that there was a problem seeing the 
isotope peak in only the plasma samples. An additional observation with the plasma 
standards was that a  slight mass shift with the isotopic glucose peak was again detected 
as with negative ion ESI. This indicates the possibility o f  another molecule co-eluting 
with [6,6 ^H] glucose. The intriguing point about the two sets o f standards was the 
inaccuracy o f  detecting enrichments for glucose that came from plasma. The enrichment 
values for both blank and enriched plasma samples indicate a molecule with the same 
molecular weight that is artificially inflating these values.
SmM Glucose KB170 9-AUG^001
09:29:55
Glucose StucJy Fresrv027e (0.021) Cu (0 05): Is (I.OO.1.00) C6H1206Na TOP MS ES+
.jQQ 203.0532 9.21 e l 2
%
204.0532 
T
Glucose study Freslv027e 54 (0.905) Cm (39:55) TOP MS ES+
.jPQ 203.1027 8.05e3
4  l \\ 204.1122
O l  ^ " 'I - T —  -  m/z
203 204 205
F igure 3.10. Positive ion ESI mode illustrating a 5mM standard solution in water (on the
bottom with the theoretical spectra on top).
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2% Plasma prep
Glucose Study Fresh-137
KB170 30rAUG-200111:27:24
TOP MS ES+
TIC 
6 80e3
1.12100-,
0.50 1.00 1 50 2.00 2.50 3.00
Figure 3.11. Positive ion ESI mode showing a total ion chromatogram o f  a 2% standard 
solution prepared from human plasma.
No E Plasma prep
Glucose Study Fresh-135 Sm (SG. 2x1 )
KB170 30-AU6-200111:19;52
TOF MS ES+
1.12:17.22 206 .124 0.20Da 
56.1 
Area
100-,
Glucose Study Fresh-135 Sm (SG. 2x1) TOF MS ES+
1.12:338.80 203 103 0 200a 
1.0263 
Area
100-,
■  %-
Time
2.00 2.50 3.000.50 1.00 1.50
Figure 3.12. Positive ion ESI mode illustrating the integration o f  background plasma 
sample a 205 to 203 ratio o f 5.08%.
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6% Plasma prep KB170
Glucose Study Fresh-140 56 (G 936) Cm (46:56)
30-AU6-2001
11:38:51
TOP MS ES+
3 90e3203.1027100-,
205 1243204.1122
m/z
203 204 205
Figure 3.13. Positive ion ESI mode representing 5% standard solution prepared from 
human plasma. Spectrum indicates an enrichment o f  approximately 10%.
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Table 3.4. Comparison o f enrichments obtained by LC/MS and GC/MS from previous
exercise study ( Tracer tracee ratio = 205/203 x 100).
Previously analyzed 
sam ples
lepolnt 203 205 205/203 LC/MS E GC/MS
-90 191.93 16.77 8.73
-15 305-6 22 .46 7 .35 -1 .39 3 .16
0 284 .05  29 .72 10.46 1.73 3.6
5 191.01 2 1 .45 11.23 2 .49 3.27
10 220.97 17.82 8 .06 -0 .67 3.32
20 190.17 20.61 10.84 2 .10 3.23
25 125.59 9 .79 7 .80 -0 .94 3 .15
30 146.61 11.93 8 .14 -0 .60 2 .94
35 220.41 19.46 8.83 0.09 3.03
40 106.64 11.04 10.35 1.62 2 .78
45 174.89 12.04 6 .88 -1 .85 2 .45
Newly acquired sam ples
epoint 203 205 205/203 LC/MS E
-60 344.86 16.21 4 .70
-2 157.72 12.93 8.20 3.50
0 175.91 18.69 10.62 5.92
10 122.4 9 .40 7 .68 2 .98
20 161.99 15.45 9.54 4 .84
25 252.03 16.92 6.71 2.01
30 100.47 7.05 7.02 2.32
4 0 256.69 15.09 5.88 1.18
50 579.4 27 .85 4.81 0.11
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GC/MS vs. LC/MS
u"Cc
UJ 20-10 10 30 40 50
Time
♦  LC/MS E 
■ GC/MS E
Figure 3.14. GC/MS vs LC/MS enrichment data.
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Figure 3.15. Standard curve for glucose spiked with 1-5% [6,6^H] glucose.
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Spiked standards in plasma
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Eaqaenmental enrichments
Figure 3.16. Standard curve for plasma samples spiked with 1-5%  [6,6 H] glucose.
Sorbitol Experiments
Sorbitol, a  reduced form o f  glucose, is a candidate for a  tracer peak contaminant with a 
molecular weight o f approximately 182.17 amu. Sorbitol would not interfere with 
GC/MS analysis, as it would form a hexaacetate derivative instead o f  the hexaacetate 
derivative that glucose forms. Figure 3.17 shows a spectrum o f  sorbitol dissolved in DDI 
water at m/z 205, the same mass as [6,6-^H] glucose. Both glucose and sorbitol peracetate 
derivatives were analyzed via LC/MS (m/z 413 and 457 respectively) and are shown in 
Figure 3.18 representing the large mass difference that occurs after derivatization. The
35
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glucose samples that were spiked with sorbitol are represented by a standard curve shown 
in Figure 3.19 (R^ = 0.9982). As indicated by the graph, the experimental values are 
approximately ten times the theoretical values. It appears that sorbitol demonstrates a 
much s tro lle r  (~ 10 times) interaction with sodium than glucose. For some reason the [M 
+ Na]^ is more likely to form with sorbitol than with glucose. I f  sorbitol is in the plasma, 
even in small amounts, it may contaminate the isotopic glucose peak, making the peak 
appear larger than predicted. Equal amounts o f  glucose and sorbitol were mixed in DDI 
water and analyzed to confirm sorbitol’s increased ability to form [M+Na]^ when 
compared to glucose. If  both molecules form the ion at the same rate, then similar peak 
intensities would are predicted. The results show a 205 peak that is much larger than the 
glucose peak formed at 203 (Fig 3.20) practically drowning out the glucose peak at 203.
A blank plasma sample was derivitized in an attempt to identify sorbitol within a plasma 
sample by its derivative m/z 457. The sample was prepared as described in the 
methodology but instead o f  reconstituting in DDI water, it was reconstituted in 2:1 acetic 
anhydride and pyridine to form the glucose and possibly the sorbitol peracetate 
derivatives. The sorbitol derivative was formed (Fig 3.21). Even small amounts o f 
sorbitol may have a large effect on tracer peak quantitation as evidenced by the standard 
curve (Fig 3.19). Sorbital in trace amounts become magnified, skewing the enrichments 
o f  [6,6-^H] glucose. A final experiment conducted involved the addition o f  equal 
amounts o f  glucose pentaacetate and sorbitol hexaacetate to DDI water. A similar trend 
was observed as occurred with the native forms o f both molecules but the results were not
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as drastic (Fig 3.22). The derivatization has illustrated sorbitol contained in the plasma. 
Additionally, the hexaacetate derivative o f  sorbitol is formed but does not interfere with 
isotopic peak calculations for the determination o f  enrichment. In order to identify the 
contaminant molecule as sorbitol, retention times on a LC column should be analyzed. If 
sorbitol elutes at the same time as glucose this would be convincing evidence that we 
have targeted the molecule responsible for skewing enrichment data.
Sorbitol
junk96987 55 (0 924) Cm (47:59)
KB170 4^EP-2001
16:04:13
TOF MS ES+
205.1725
2DB.1G29
129.1088 1726508 .222.6664 293 2436
m/z
180 240 260 280 300 320120 140 160 200 220
Figure 3.17. Spectrum o f  Sorbitol m/z 205.
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Glucose/Sorbitoi Derivatives
Junk96986 56 (0.936) Cm (47:57) 
IDOt
KB170
457.3056
4-SEP-2001
15:56:20
TOF MS ES+
1 03e4
% -
413.2456
406.2949I .
414.2736
429.2535
4
452.3476
I I I I I I I I I f  .r f ‘r | T 'T 'r 'i’''n ’i'''i' i 'I ' l    y  i r » p r p i"'T " i.....
405 410 415 420 425 430 435 440 445 450 455 460 465 470
458.3149
m/z
F igure 3.18. Spectrum o f glucose pentaacetate (m/z 413) and sorbitol hexaacetate (m/z 
457).
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Figure 3.19 5 mM glucose solution spiked 1-5 % with Sorbitol.
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5 mM glucose + Sorbitol KB170
Glucose Study Fresn-179a 56 (0.936) Cm (50:61)
7-SEP-2001
15:43:16
TOF MS ES+
3.22e4205.1243100-,
% -
206.1387
- r ^
206
m/z
203 204 205
F igure  3.20. Equal amounts o f  glucose and sorbitol in DDI water.
Derivative 60 ul KB170
Glucose Study Fresh-186 59 (0.986) Cm (57:65) 
lOOn ''57.2336
11-SEP-2001
09:53:37
TOF MS ES+ 
45
% -
458.2975 457.3777 45Q.4231 459.3613 
458.8921, 480.4091 461.4217 .c-, otcq
m/z
456 457 458 459 460 461 462
F igure  3.21. Sorbitol hexaacetate detected in background plasma sample.
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glc penta + sorb, hexa-acetate KB170
Glucose Study Fresh-188a 57 (0.952) Cm (52:61 )
11-SEP-2001 
12:34:45
TOP MS ES+
3.9564457.3416100-1
413.3141 452.3834
458.3510 473.3308
m/z
390 400 410 420 430 440 450 460 470 480 490 500
Figure 3.22. Equal amounts o f  glucose pentaacetate and sorbitol hexaacetate in DDI 
water.
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Conclusion
The results suggest that o f the three ionization techniques explored, positive ion ESI 
LC/MS produced the best data with respect to the signal to noise and signal intensity. 
Standards prepared in water were accurately measured however, standards prepared from 
plasma were not. The separation o f  glucose from other molecules in plasma is not 
achieved by the sample preparation and LC/MS techniques. Therefore, this LC/MS 
method is inadequate at determining the enrichment o f  [6,6-^H] glucose in plasma. 
Further research to elucidate the identity o f  a contaminant molecule and the development 
o f  a more effective separation technique is needed. This research should investigate 
using a quadrupole analyzer, which may increase the instruments sensitivity. Also, the 
use o f  carbohydrate LC columns made to separate monosaccharides will likely enhance 
glucose separation. Although ESI LC/MS has revolutionized many areas o f  scientific 
research a definitive method for the determination o f  isotopic glucose enrichment 
remains elusive.
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Human Perform ance Laboratory 
The University fo Montana
Personal Data Sheet
N am e_______________ __________________________________________
A ddress __________________________________________
P hone Number(s) __________________________________________
Age
in c a se  of an em ergency, contact (closest relative)
Name _____________________________________
Relation _____________________________________
Phone _____________________________________
A ddress
Menstrual History
1. Have you had a  normal period for at least the last 6 m onths?
2. W hat is your history usinging oral birth control (what kind, how long)?
3. W hen w as your last period?
4. How many days is your cycle (20,30)?
Exercise History
1. D escribe the type of exercise (duration, intensity and frequency) you participate in
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HUMAN PERFORMANCE LABORATORY 
Dept of Health and Human Performance 
UNIVERSITY OF MONTANA 
Missoula, Montana
SUBJECT INFORMATION AND CONSENT FORM
_______  ID # ________  Today’s Datej /_____ / ______ Participant
(Print Name) Month Day Year
A menstrual phase comparison in eumenorrheic females: 
glucose kinetics during submaximal exercise in response to an
oral glucose load - Research
STUDY DIRECTOR(S): Kristin Bourret (406)542-1296 University of Montana
Brent Ruby, Ph.D. (406)243-2117 University of Montana 
Steven Gaskili, Ph.D. (406) 243-4268 University of Montana
This consent form may contain words that are new to you. If you read any words that are not 
clear to you, please ask the person who gave you this form to explain them to you.
The purpose of this investigation is to determine if the menstrual cycle may alter which 
muscle fuel (carbohydrate and fat) I use during submaximal exercise. The information 
collected from this study should help determine if females have different fuel 
requirements during each phase of the menstrual cycle while performing exercise.
Participation in this study will include 1) pre-screening questionnaires to determine 
health and menstrual history as well as exercise training habits ("30 minutes), 2) a 
measure of percent body fat obtained by measuring my body weight underwater (~ 1 
hour), 3) a measure of my leg volume obtained by measuring leg circumferences, leg 
length, and leg width ("20 minutes), 3) a cycling test to determine my body's maximal 
ability to consume oxygen and at what intensity my anaerobic threshold occurs (~ 1 
hour), 4) two 60-minute cycling trials that will involve the infusion of about 1 gram of a 
glucose stable isotope ("3.5 hours each totaling 7 hours). The total time commitment is 
estimated at -  9 hours and 50 minutes spread out over 4 laboratory visits.
Following the completion of the pre-screening questionnaires my leg volume and body 
composition will be measured. Two different measures are necessary to calculate my 
body composition (the amount of muscle and fat on your body): 1) helium breathing 
technique to determine the amount of trapped air in my lungs after I exhale maximally, 
and 2) underwater weighing. This procedure will require that I be seated in a large tank 
of water and weighed when completely submerged with the air completely exhaled from 
my lungs (I will be underwater for approximately 15 seconds per trial). For this trial, I am 
to bring a bathing suit and towel. This procedure will take approximately one hour total.
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Leg volume measurements will be taken to estimate my leg muscle size. This uses a 
skinfold technique, similar to what is frequently used in health clubs to estimate body 
composition. The technique uses a caliper to measure specific folds of skin in different 
areas of my leg. Additionally circumferences and leg diameter will be measured with a 
tape measure. Leg volume measurements will take approximately 20 minutes.
The cycling maximal oxygen consumption/anaerobic threshold test will require me to 
work at increasing resistance until near exhaustion. The test will require that I have a 
venous catheter inserted in my arm and remain there for the duration of the test. Blood 
samples will be obtained every two minutes (approximately Vz teaspoon each, total 
estimate 5-6 teaspoons). I will breathe into a mouthpiece to monitor how much oxygen I 
am using. This test will take approximately 1 hour.
The 60-minute cycling trial will require me to report to the Human Performance Lab early 
in the morning (~5AM). indwelling venous catheters will be inserted into one vein in 
each arm for blood sampling and infusion of a glucose stable isotope during rest and 
cycling. I will rest on a bed for approximately 100 minutes with catheters in place before 
the cycling trial. After 100 minutes I will drink a solution containing glucose in a 
concentration similar to soda (22%), then I will continue to rest for 30 additional minutes 
before starting exercise. The cycling trial will consist of riding an exercise bike for 60 
minutes at a moderately hard intensity. This test will require that I breathe into a 
mouthpiece to monitor oxygen use during exercise. This test will take approximately 3.5 
hours. Blood samples will be obtained every 5 minutes during exercise and three times 
before exercise totaling approximately 2.5-3.0 fluid ounces (-75-80 mL). Transportation 
will be provided for me.
I will not exercise during the 15 hours prior to any test and will not consume any food for 
10 hours prior to each test (with the exception of body composition testing). I will also 
provide a list of foods consumed in the previous 48 hours before the 30-minute cycling 
trial. I will report to the Human Performance Laboratory in room #121 in McGill Hall for 
all of my testing.
It is expected that I will have minimal discomfort as a result of my participation in this 
study. Nausea and the possibility of vomiting may occur in response to the oral glucose 
load. The graded cycle ergometry test has certain risks associated with it including loss 
of consciousness and stroke (0.05% of the time), heart attack and death (0.005% of the 
time) or musculoskeletal injury or muscle soreness. Although the risks associated with 
these tests are minimal, all testing will be conducted under the guidelines for exercise 
testing observed by the American College of Sports Medicine. Blood sampling (veno- 
puncture) can sometimes be associated with risks of bruising (10%), infection (less than 
1%) and clotting problems (less than 1%). All of these risks will be minimized by the use 
of sterile procedures and trained technicians. There are no known risks associated with 
the presence of stable isotopes in the body, as they are naturally present.
All exercise testing and blood sampling will be supervised and conducted by Brent C. 
Ruby, Ph.D. an Exercise Physiologist and trained phlebotomist and his trained staff of 
assistants. In the event you are injured while participating in this research study, you
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should contact Dr. Ruby in the lab (406-243-2117) or at home (406-542-2513). All 
results will be kept In strict confidence among the subject Involved and the Principal 
Investigators and other Co-Investigators. During the entire period of data collection, 
subject records will be kept within the Human Performance Laboratory and will be locked 
under the direction of the Principal Investigator.
BENEFITS OF PARTICIPATING IN THIS STUDY
1. There is no promise that you will receive any benefit from taking part in this study.
2. You will receive information concerning body composition that may be compared 
with norms for your age, sex and sport. You will also receive information on your 
maximal aerobic capacity and anaerobic threshold, which you may compare with 
norms for your age, sex and sport. There are no other direct benefits to the 
participants in the study.
CONFIDENTIALITY
1. Your records will be kept private and will not be released without your consent 
except as required by law.
2. Only the researcher and his faculty supervisor will have access to the files.
3. Your identity will be kept confidential.
4. If the results of this study are written in a scientific journal or presented at a scientific 
meeting, your name will not be used.
5 All data, identified only by an anonymous ID #, will be stored in our laboratory.
6. Your signed consent form and information sheet will be stored in a locked office 
separate from the data.
COMPENSATION FOR INJURY
Although we believe that the risk of taking part in this study is minimal, the 
following liability statement is required in all University of Montana consent forms. “In 
the event that you are injured as a result of this research you should individually seek 
appropriate medical treatment. If the injury is caused by negligence of the University or 
any of its employees, you may be entitled to reimbursement pursuant to the 
Comprehensive State Insurance Plan established by the Department of Administration 
under the authority of M. C.A., Title 2, Chapter 9. In the event of a claim for such injury, 
further information may be obtained from the University’s Claim representative or 
University Legal Counsel, "
VOLUNTARY PARTICIPATION/WITHDRAWAL
1. You have the right to request that a test be stopped at any time.
2 Your decision to take part in this research study is entirely voluntary.
3. You may refuse to take part in or you may withdraw from the study at any time 
without penalty or loss of benefits to which you are normally entitled.
4. You may leave the study for any reason.
You may be asked to leave the study for any of the following reasons:
1. Failure to follow the study investigator’s instructions.
2. A serious adverse reaction, which may require evaluation.
47
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3. The study director/investigator thinks it is in the best interest of your health and 
welfare.
4. The study is terminated.
QUESTIONS
•  You may wish to discuss this with others before you agree to take part in this study.
•  If you have any questions about the research now or during the study contact: Brent 
Ruby (406) 243-2117 or Steven Gaskili (406) 243-4268.
•  If you have any questions regarding your rights as a research subject, you may contact 
the Chairman, J.A. Rudbach, of the IRB through the Research Office at the University of 
Montana at 243-6670.
SUBJECT’S STATEMENT OF CONSENT
I have read the above description of this research study. I have been informed of 
the risks and benefits involved, and all my questions have been answered to my 
satisfaction. Furthermore, I have been assured that a member of the research team will 
also answer any future questions I may have. I voluntarily agree to take part. I 
understand I will receive a copy of this consent form.
Printed (Typed) Name o f Subject
Subject’s Signature Date
SUBJECT’S STATEMENT OF CONSENT TO BE PHOTOGRAPHED DURING DATA 
COLLECTION
I provide my consent to be photographed during periods of the data collection. 1 
realize that these digital images may be used during presentation of the data at regional 
and national meetings.
Subject’s Signature Date
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